Personalized medicine continues to advance -- new cancer treatment offerings from Champions Biotechnology

A couple of years ago, we at Stinson Brand Innovation were developing a Strategic GPS^® for a client's new diagnostic instrument. A pivotal part of the insight was a vision of "personalized therapy." And we're seeing it come to reality more and more every day.

Champions Biotechnology, a company offering personalized cancer data for patients and physicians, has launched a new website: www.personalizedcancertreatment.com. The website details Champions' personalized treatment offerings for cancer patients and their physicians, including tumorgrafts, vaccines and expert oncology panels – all catering to individual cancer patients.


“Champions offers a more precise approach to cancer treatment, because every patient's cancer is unique,” said Doug Burkett, president of Champions Biotechnology, in a statement. “In partnership with one's physician, Champions optimizes a given treatment plan's potential for success and maximizes the patient's most precious resource: time.” The personalized tumorgraft, for example, uses a sample of the patient's living tumor in order to test treatment options “through simultaneous evaluation of the effectiveness of numerous anti-cancer drugs.”

The company is currently developing several of its own oncology products, but also has partnered with other biotechs including Centocor, ImClone, Concordia Pharmaceuticals and Gradalis. Personalized vaccines utilize tumorgrafts to predict a patient's immune system response to a given treatment.

If you're seeing other examples of personalized medicine, please share them in the comments below.